about
Serum prolidase activity and oxidant-antioxidant status in children with chronic hepatitis B virus infectionLiver involvement in subjects with rheumatic diseaseEntecavir for chronic hepatitis BPhyllanthus species versus antiviral drugs for chronic hepatitis B virus infectionAntiviral agents for hepatitis B virus-related cirrhosisPhyllanthus species for chronic hepatitis B virus infectionCombination Therapy for Chronic Hepatitis B: Current IndicationsAntiviral drugs for viruses other than human immunodeficiency virusHepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention StrategiesPrevention of Hepatitis B reactivation in the setting of immunosuppressionKASL clinical practice guidelines: management of chronic hepatitis BThe Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and ChallengesManagement of hepatitis B reactivation in immunosuppressed patients: An update on current recommendationsChronic Hepatitis B with Spontaneous Severe Acute ExacerbationControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaProphylactic managements of hepatitis B viral infection in liver transplantationSignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaHepatic manifestations of non-steroidal inflammatory bowel disease therapyHepatitis B virus therapy: What's the future holding for us?The Role of Oxidative Stress and Antioxidants in Liver DiseasesAntiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus InfectionUpdate on Hepatitis B Virus Infection: Focus on TreatmentHepatitis B and Hepatitis C Reactivation in the Biologic EraPrediction of fibrosis progression in chronic viral hepatitisTumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature reviewDoes antiviral therapy reduce complications of cirrhosis?Application of nucleoside analogues to liver transplant recipients with hepatitis BΜanagement of patients with hepatitis B and C before and after liver and kidney transplantationHepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawalAntiviral therapy for chronic hepatitis B in ChinaManagement of chronic hepatitis B infection: current treatment guidelines, challenges, and new developmentsThe importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysisManagement of patients with hepatitis B in special populationsOutcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factorsManagement of chronic hepatitis B before and after liver transplantationManagement of chronic hepatitis B in pregnancyNew virologic tools for management of chronic hepatitis B and CNucleoside/nucleotide analogues in the treatment of chronic hepatitis BSmartphone-Imaged HIV-1 Reverse-Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) on a Chip from Whole Blood.What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?
P2860
Q21146641-FB337A0E-7DFA-48A0-9876-22DCF05D1EF0Q22000839-19419DA1-41A1-4C1F-8213-5328603603D0Q24194997-CE0F5A2C-0958-4195-97A2-5917759EB7E5Q24197858-30E3C592-9518-4752-8A21-4BFA9B74203EQ24200681-244ED74A-AAAA-433E-8D9F-92B8C08105F9Q24235128-B0AB73DE-0B23-48A7-B0D9-0D64202F541BQ24604492-1DE1AF9C-9410-4526-B85B-B5B115B3A440Q24635330-84E1E104-ABAC-45D4-9183-3DA88C5EF114Q26746486-D008EBF9-B1CF-4893-ACF4-3CCED2D68082Q26747023-BF850FB2-7458-4B0F-9BF3-36E9776A07EAQ26752475-7E0056CA-3CF0-4E0F-A8B5-63C34576A94BQ26752620-BB6B37C8-87D1-4D0D-BCF7-3DFD1C9F5098Q26752690-C499D7E0-5872-4E84-A9F3-E7235DC738C3Q26772036-D7722095-9C0F-461A-8855-2442BB6605FCQ26772324-444E16BF-DC7B-49A2-B862-0AA76A8783E8Q26772340-3F55470C-BCDF-4C4F-8F6B-321E4F6F7776Q26773251-A95CB551-ED0E-4560-8676-FC7228B3E7A9Q26773684-2A997561-87E2-48A2-AB50-A1EF9100EE94Q26774198-AA41604F-151A-46A5-B5D0-C0A421331512Q26779146-DB54D95B-FAAE-4C74-A5BE-51FCF4E5B122Q26781962-5F2759AF-DA46-4FF7-9AEF-697670FCAC2EQ26781990-4B5ED918-68C3-4BA0-99A8-360A0FCB31DEQ26781993-094CC682-E5D3-4411-9786-FA8CD014A931Q26823671-07925326-9A27-4C7F-BDE1-A644164E435DQ26829390-59A82C52-4CCE-49AB-9CE3-5F94C0F89623Q26851410-BB03996D-BE6F-4928-BABE-3730DFDFBAB8Q26859796-50EE934C-AB38-4DF3-A998-229204FC679BQ26864647-143A1FC7-45C0-4172-B35D-2FA4EF06B396Q26995814-47D516C7-2C0E-4802-B65D-F53F66FAB9C0Q27006557-81847AB7-FE3F-4A25-96C9-C5A2ABB105BBQ27008984-8B06D77F-174A-4040-942D-0B3046814D71Q27016075-A45E2BAA-FCEC-4A34-9E2C-E3FF4723FA83Q27016136-A81A3BF7-BBC7-4A02-85E6-939680C928C2Q27020938-F3BE884E-238F-441C-AECA-4D944EAF9122Q27024831-E1D318AF-DDDA-4639-A011-000644AFCCD4Q27026593-99CE98F7-5314-4368-A251-814C47BFFECDQ27026914-EBA8714F-2711-4211-9255-78E1CC965891Q27030828-C24BFE23-1A09-4232-AB08-C8FD704F670AQ27347920-7056EB26-1278-4F3A-8FDE-3266485E1D04Q27687191-EC32EE6F-8CE7-468F-BFA3-A4676AA77308
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chronic hepatitis B: update 2009
@ast
Chronic hepatitis B: update 2009
@en
type
label
Chronic hepatitis B: update 2009
@ast
Chronic hepatitis B: update 2009
@en
prefLabel
Chronic hepatitis B: update 2009
@ast
Chronic hepatitis B: update 2009
@en
P3181
P356
P1433
P1476
Chronic hepatitis B: update 2009
@en
P2093
P3181
P356
10.1002/HEP.23190
P407
P577
2009-09-01T00:00:00Z